Cancer

Baird Medical Announces First Successful Liver Tumor Ablation in Bangladesh

NEW YORK, Oct. 23, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD), a global leader in minimally invasive Microwave…

4 months ago

Investors Turn to AI-Driven Imaging Firms Targeting High-Growth Breast Cancer Market

NetworkNewsWire Editorial Coverage NEW YORK, Oct. 23, 2025 /PRNewswire/ -- Artificial intelligence (AI) continues to transform healthcare innovation, with medical…

4 months ago

MedCognetics Collaborates With Laurel Bridge Software to Revolutionize Breast Cancer Screening and Diagnosis With Secure, Advanced AI Workflow Solutions

NEWARK, DELAWARE / ACCESS Newswire / October 23, 2025 / MedCognetics, a pioneer in artificial intelligence (AI) for breast cancer…

4 months ago

Telomir Pharmaceuticals Reports New Data Showing Telomir-1 Resets Cancer’s “Kill-and-Clean” Defense Systems in an Aggressive Prostate Cancer Model, Outperforming Rapamycin and Chemo

New findings highlight Telomir-1's impact on CASP8 and GSTP1, two critical genes that regulate cell death and glutathione-based detoxification pathways…

4 months ago

Biofrontera Inc. Closes Purchase of All Ameluz® and RhodoLED® US Assets from Biofrontera AG

Biofrontera Inc. acquires full U.S. rights to Ameluz® and RhodoLED®, including New Drug Application and associated patents, from former parent…

4 months ago

MAIA Biotechnology Details 30-Month Patient Survival in Ongoing Phase 2 Clinical Trial in Non-Small Cell Lung Cancer

Outstanding measure of efficacy relative to high-risk cancers with limited treatment options CHICAGO, Oct. 23, 2025 (GLOBE NEWSWIRE) -- MAIA…

4 months ago

Izotropic CEO Interview: IzoView Differentiators, Regulatory Plans, and Outlook

Vancouver, British Columbia, and Sacramento, California--(Newsfile Corp. - October 23, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3)…

4 months ago

BioNxt Enters the Final Stretch Before Human Trials for Next-Generation MS Drug

NEW YORK, Oct. 23, 2025 /PRNewswire/ -- BioNxt Solutions Inc. (CSE:BNXT) (OTCQB:BNXTF) (FSE:BXT), a bioscience company developing next-generation drug delivery…

4 months ago

Defence to Present New Scientific Data on Its ADC-Enhancing Accum Technology at the World ADC Conference in San Diego, USA, November 4-5, 2025

Montreal, Quebec--(Newsfile Corp. - October 23, 2025) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the…

4 months ago

MGI Tech partners with Eva Holding Group to enhance the accuracy of disease monitoring

SÃO PAULO, Oct. 22, 2025 /PRNewswire/ -- MGI Tech Co., Ltd. ("MGI"), a company dedicated to developing essential tools and technologies…

4 months ago